VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
COSM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
COSMCosmos Health Inc.
$0.26$14M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

COSM logoCosmos Health Inc.(COSM)Earnings, Financials & Key Ratios

COSM•NASDAQ
$0.26
Price updated Jul 7, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryConsumer health and OTC self-care
AboutCosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.Show more
  • Revenue$65M+19.9%
  • EBITDA-$15M-6.1%
  • Net Income-$19M-18.3%
  • EPS (Diluted)-0.63+46.2%
  • Gross Margin12.1%+52.7%
  • EBITDA Margin-23.24%+11.5%
  • Operating Margin-25.34%+11.3%
  • Net Margin-29.33%+1.4%
  • ROE-89.13%-66.8%

COSM Price & Volume

Cosmos Health Inc. (COSM) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operational Losses Threaten Capital Structure Stability

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Expanding
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity and dilution

Key Thesis Takeaways

  • Cosmos Health exhibits a concerning pattern of aggressive revenue expansion, evidenced by a 38.5% growth rate in 2025Q4, which fails to translate into operational profitability due to structural margin compression and high fixed costs.
  • The company's reliance on debt financing, with a debt-to-equity ratio that climbed to 1.08 by 2025Q4, combined with a precarious cash position of only $514.7K as of 2026Q1, suggests significant liquidity risk.
  • Investors should remain cautious as the persistent erosion of shareholder equity and reliance on stock-based compensation, such as the $582K recorded in 2025Q4, indicate a lack of a clear path to sustainable cash flow generation.

Verdict Logic

the company's precarious liquidity position, highlighted by a cash balance of only $514.7K against a $18.5M debt load in 2026Q1, presents an imminent risk of further dilutive financing.

COSM Growth Metrics

Cosmos Health Inc. (COSM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years61.71%
5 Years3.33%
3 Years9.04%
TTM29.75%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-39.63%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM41.99%

Return on Capital

10 Years-23.77%
5 Years-41.43%
3 Years-51.07%
Last Year-59.33%

COSM Recent Earnings

Cosmos Health Inc. (COSM) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 5/12 qtrs (56%)●Beat Revenue 4/12 qtrs (44%)
Q2 2026Latest
May 20, 2026
Metric
Actual
Est
EPS
$0.33-725.0%
$0.04
Rev
$20M+4.7%
$19M
Q4 2025
Nov 14, 2025
Metric
Actual
Est
EPS
$0.17-1600.0%
$0.01
Rev
$17M+4.3%
$16M
Q3 2025
Aug 18, 2025
Metric
Actual
Est
EPS
$0.06-700.0%
$0.01
Rev
$15M-15.6%
$17M
Q2 2025
May 15, 2025
Metric
Actual
Est
EPS
$0.01+133.3%
$0.03
Rev
$14M-11.5%
$16M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 20, 2026
$0.33vs $0.04-725.0%
$20Mvs $19M+4.7%
Q4 2025Nov 14, 2025
$0.17vs $0.01-1600.0%
$17Mvs $16M+4.3%
Q3 2025Aug 18, 2025
$0.06vs $0.01-700.0%
$15Mvs $17M-15.6%
Q2 2025May 15, 2025
$0.01vs $0.03+133.3%
$14Mvs $16M-11.5%
Based on last 12 quarters of dataView full earnings history →

Latest COSM News

Recent stock market news and headlines for Cosmos Health Inc. (COSM)

GlobeNewsWire·5 days ago
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases

CHICAGO, July 02, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 770,000 shares of its common stock in the open market at an average price of approximately $0.1956 per share, extending the buyback activity it began this week. The Company has now repurchased a total of 3,420,000 shares for approximately $650,000 under its previously announced share repurchase program of up to $5 million.

GlobeNewsWire·6 days ago
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace

CHICAGO, July 01, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”)  (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased 2,650,000 shares of its common stock for a total of $500,000 in the open market, at an average price of approximately $0.1887 per share. The repurchases were made pursuant to the share repurchase program of up to $5 million announced on June 30, 2026, under which the Company may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means in accordance with SEC Rules 10b5-1 and 10b-18 and other applicable restrictions.

Globe News Wire·6 days ago
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace

CHICAGO, July 01, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ: COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased 2,650,000 shares of its common stock for a total of $500,000 in the open market, at an average price of approximately $0.

GlobeNewsWire·Jun 30, 2026
Cosmos Health Authorizes Up to $5 Million Share Repurchase Program

CHICAGO, June 30, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”)  (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that its Board of Directors has authorized a share repurchase program of up to $5 million of the Company's common stock. Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means in accordance with SEC Rules 10b5-1 and 10b-18 and other applicable restrictions.

Globe News Wire·Jun 26, 2026
Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

CHICAGO, June 26, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ: COSM), a diversified, vertically integrated global healthcare group, today announced a distribution agreement with International Medical Company ("IMC") to expand its presence in the State of Qatar for its proprietary Sky Premium Life line of nutraceuticals and food supplements.

Peers Comparison

Key metrics vs top competitors for Cosmos Health Inc. (COSM)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
COSM logoCOSMCosmos Health Inc.Current
$0.26$13.97M-0.4119.93%-29.33%-89.13%—
HROW logoHROWHarrow Health, Inc.
$46.15$1.72B-329.6436.41%-5.57%-33.92%—
NTRB logoNTRBNutriband Inc.
$3.03$36.83M-1.17-4.83%-448.39%-112.6%—
XTLB logoXTLBXTL Biopharmaceuticals Ltd.
$2.98$327.88K-0.31—-227.72%-25.53%—
CODA logoCODACoda Octopus Group, Inc.
$9.30$104.91M25.1430.75%17.66%8.33%—
PHVS logoPHVSPharvaris N.V.
$34.59$2.26B-10.19——-67.38%—

Compare COSM vs Peers

Cosmos Health Inc. (COSM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HROW

Most directly comparable listed peer for COSM.

Scale Benchmark

vs MCK

Larger-name benchmark to compare COSM against a more recognizable public peer.

Peer Set

Compare Top 5

vs HROW, NTRB, XTLB, CODA

COSM SEC Filings & Documents

Cosmos Health Inc. (COSM) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 22, 2026·SEC

Material company update

Apr 16, 2026·SEC

Material company update

Dec 18, 2025·SEC

10-K Annual Reports

3
FY 2026

Apr 15, 2026·SEC

FY 2025

Apr 15, 2025·SEC

FY 2024

Aug 5, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 20, 2026·SEC

FY 2025

Nov 14, 2025·SEC

FY 2025

Aug 18, 2025·SEC

Get notified when COSM posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

COSM Frequently Asked Questions

Cosmos Health Inc. (COSM) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Cosmos Health Inc.'s revenue?

Cosmos Health Inc. (COSM) reported $69.5M in revenue for fiscal year 2025.

How fast is Cosmos Health Inc. growing?

Cosmos Health Inc. (COSM) grew revenue by 19.9% over the past year. This is strong growth.

Is COSM profitable?

Cosmos Health Inc. (COSM) reported a net loss of $21.1M for fiscal year 2025.

Dividend & Returns
What is COSM's return on equity?

Cosmos Health Inc. (COSM) has a return on equity (ROE) of -89.1%. Negative ROE indicates the company is unprofitable.

What is Cosmos Health Inc.'s free cash flow?

Cosmos Health Inc. (COSM) had negative free cash flow of $11.1M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in COSM back in 2009?

Total return calculator · dividends reinvested · 17+ years of data

See returns →